721 results on '"Benn, Peter"'
Search Results
2. Noninvasive Prenatal Testing for Early Sex Identification: A Few Benefits and Many Concerns
3. 'RATs': Rare Autosomal Trisomies and Their Relevance in cfDNA Testing
4. Cell‐free DNA fetal fraction in twin gestations in single‐nucleotide polymorphism‐based noninvasive prenatal screening
5. Overview of Noninvasive Prenatal Testing (NIPT) for the Detection of Fetal Chromosome Abnormalities; Differences in Laboratory Methods and Scope of Testing
6. Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy.
7. Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States
8. Rare autosomal trisomies detected by non-invasive prenatal testing
9. 1152 Positive Carrier Screening for Alport Syndrome: A Need for Greater Awareness
10. 143 Accuracy of fetal fraction measurements in SNP-based non-invasive prenatal testing (NIPT)
11. 250 Preimplantation genetic testing (PGT) for non-homologous Robertsonian translocation carriers: a twelve-year laboratory experience
12. Single gene non‐invasive prenatal testing when the father is not available for testing; concerns regarding Wynn et al., Prenatal Diagnosis 2023. 43:1344–54
13. Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach
14. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA
15. Non-invasive prenatal screening: A 20-year experience in Italy
16. Correspondence on “Maternal carrier screening with single-gene NIPS provides accurate fetal risk assessments for recessive conditions” by Hoskovec et al
17. Reproductive Carrier Screening Results With Maternal Health Implications During Pregnancy
18. Maternal plasma cell-free DNA screening
19. Maternal plasma cell-free DNA screening
20. Reproductive Carrier Screening Results With Maternal Health Implications During Pregnancy.
21. P681: Carrier screening with the ACMG 113: An early look and new insights
22. P651: Bleeding complications in pregnant carriers of factor IX and factor XI ascertained through carrier screening
23. A National Referral Laboratory’s Experience with the Implementation of SNP-Based Non-invasive Prenatal Screening for Fetal Aneuploidy and Select Microdeletion Syndromes
24. Response to Sistermans et al.
25. Response to Toutain et al.
26. Cell-free DNA screening for fetal aneuploidy as a clinical service
27. Positive predictive values and outcomes for uninformative cell‐free DNA tests: An Italian multicentric Cytogenetic and cytogenomic Audit of diagnOstic testing (ICARO study)
28. Assessment of an automated approach for variant interpretation in screening for monogenic disorders: A single‐center study
29. The Significance of Test Failures in Noninvasive Prenatal Screening for Fetal Aneuploidy Using Cell-free DNA
30. Correction: Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach
31. A Critical Evaluation of Validation and Clinical Experience Studies in Non-Invasive Prenatal Testing for Trisomies 21, 18, and 13 and Monosomy X
32. Factors Associated With Informative Redraw After an Initial No Result in Noninvasive Prenatal Testing
33. Non-invasive Prenatal Testing (NIPT): The Probability of a Redraw Following a No-call [6E]
34. A Founding Father of Reproductive Genetics: Eugene Pergament (1933‐2022)
35. Non‐invasive prenatal screening for fetal triploidy using single nucleotide polymorphism (SNP)‐based testing: Differential Diagnosis And Clinical Management In Cases Showing An Extra Haplotype
36. Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma
37. Comment on “The clinical utility of genome‐wide non invasive prenatal screening”
38. Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis
39. Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects
40. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes
41. Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing
42. Noninvasive Prenatal Testing Using Cell-free DNA in Maternal Circulation
43. Ethical and practical challenges in providing noninvasive prenatal testing for chromosome abnormalities: an update
44. Current controversies in prenatal diagnosis 1: should NIPT routinely include microdeletions/microduplications?†
45. The Role of Second-Trimester Serum Screening in the Post–First-Trimester Screening Era
46. Utilization of Amniocentesis by Women Screening Positive for Down Syndrome on the Second-Trimester Triple Test
47. Positive predictive values and false-positive results in noninvasive prenatal screening
48. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis†‡
49. Noninvasive prenatal testing for 22q11.2 deletion syndrome: deeper sequencing increases the positive predictive value
50. Clinical experience and follow-up with large-scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.